Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000770319 | SCV000901753 | uncertain significance | Cardiomyopathy | 2015-09-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002533959 | SCV002982912 | uncertain significance | Hypertrophic cardiomyopathy | 2022-07-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 626757). This variant has not been reported in the literature in individuals affected with MYBPC3-related conditions. This variant is present in population databases (rs372821359, gnomAD 0.007%). This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 1223 of the MYBPC3 protein (p.Glu1223Gly). |